Surgery Partners (SGRY) Return on Capital Employed (2015 - 2026)

Surgery Partners has disclosed Return on Capital Employed across 12 years of filings, most recently posting 5.25% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 5.25%, up 69.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.25% (up 69.0% YoY), and the FY2025 annual result was 5.27%, up 11.0% from the prior year.
• Return on Capital Employed came in at 5.25% for Q1 2026 at Surgery Partners, roughly flat from 5.25% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 6.32% in Q3 2022 to a low of 4.55% in Q1 2025.
• The 5-year median for Return on Capital Employed is 5.2% (2023), against an average of 5.3%.
• Across the five-year window, Return on Capital Employed surged 148 bps in 2022 and tumbled 127 bps in 2023, its largest moves.
• Surgery Partners' Return on Capital Employed stood at 5.64% in 2022, then dropped by 8 bps to 5.2% in 2023, then retreated by 5 bps to 4.92% in 2024, then rose by 7 bps to 5.25% in 2025, then declined by 0 bps to 5.25% in 2026.
• The last three Return on Capital Employed figures came in at 5.25% (Q1 2026), 5.25% (Q4 2025), and 5.52% (Q3 2025), per Business Quant data.